CLINICAL TRIALS PROFILE FOR UNIRETIC
✉ Email this page to a colleague
All Clinical Trials for UNIRETIC
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00834067 ↗ | Moexipril HCl/Hydrochlorothiazide 15/25 mg Tablets Under Non-Fasting Conditions | Completed | Teva Pharmaceuticals USA | Phase 1 | 2003-10-01 | The objective of this study is to compare the relative bioavailability of moexipril HCl/ hydrochlorothiazide 15/25 mg tablets (manufactured and distributed by TEVA Pharmaceuticals USA) with that of UNIRETIC® 15/25 mg tablets (Schwartz Pharma) in healthy, adult, non-smoking subjects under non-fasting conditions. |
| NCT00835042 ↗ | Moexipril HCL/Hydrochlorothiazide 15/25 mg Tablets Under Fasting Conditions | Completed | Teva Pharmaceuticals USA | Phase 1 | 2003-10-01 | The objective of this study is to compare the relative bioavailability of Moexipril HCl/hydrochlorothiazide 15/25 mg tablets (manufactured and distributed by TEVA Pharmaceuticals USA) with that of UNIRETIC® 15/25 mg tablets (Schwartz Pharma) in healthy, adult non-smoking subjects under fasting conditions. |
| NCT00990301 ↗ | A Study to Compare the Relative Bioavailability of Moexipril HCl/Hydrochlorothiazide in Healthy Adult Volunteers Under Fasting Conditions | Completed | Paddock Laboratories, Inc. | Phase 1 | 1969-12-31 | The purpose of this study was to evaluate the relative bioavailability of Paddock Laboratories, Inc.'s test formulation of Moexipril/ Hydrochlorothiazide 15mg/25mg tablets with a reference formulation Uniretic®(Moexipril/ Hydrochlorothiazide) 15mg/25mg tablets, under fasting conditions. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for UNIRETIC
Condition Name
Clinical Trial Locations for UNIRETIC
Trials by Country
Clinical Trial Progress for UNIRETIC
Clinical Trial Phase
Clinical Trial Sponsors for UNIRETIC
Sponsor Name
